Ironwood Investment Counsel, LLC initiated a new stake in Professionally Managed Portfolios - Akre Focus ETF (NYSE:AKRE) during the fourth quarter, acquiring 344,154 shares in a trade estimated at $22.55 million based on quarterly average pricing, according to a February 5, 2026, SEC filing. What happened According to an SEC filing dated February 05, 2026, Ironwood Investment Counsel, LLC disclosed a new position in Professionally Managed Portfolios - Akre Focus ETF (NYSE:AKRE). The fund acquired 344,154 ...

Group 1: Tech Stock Performance - Tech stocks have declined for a second consecutive day, with Nvidia shares dropping 2% following a previous 5% decline, raising concerns about their $30 billion investment in OpenAI and the sustainability of hyperscalers' capital spending for AI [1] - Amazon shares, which invested $50 billion in OpenAI, also experienced a drop in share price, indicating a shift in market sentiment from bullish to bearish for these tech stocks [2] Group 2: Software Sector Challenges - Major software companies are projected to finish February with significant financial losses, with Salesforce falling over 4% and Microsoft down nearly 2%, while Zscaler and CoreWeave reported disappointing outlooks with losses of 11% and 16% respectively [3] - The iShares Expanded Tech-Software ETF is down 10% for the month, leading to year-to-date losses of 23%, and the Nasdaq composite index is experiencing its worst month since last March with an overall decline of over 3% [3] Group 3: Broader Economic Concerns - The decline in share values is not limited to the tech sector, as financial and other sectors are also affected by fears regarding AI's potential impact on jobs and the economy, highlighted by Block, Inc.'s announcement of laying off over 4,000 workers [4] - As of late February, the S&P 500 is down more than 1% for the month, while the Dow Jones has only increased by 0.3%, marking a disappointing end to what was expected to be a strong year [4]

MINNEAPOLIS--(BUSINESS WIRE)--Donaldson Company, Inc. (NYSE: DCI), a leading worldwide provider of innovative filtration products and solutions, today announced Rich Lewis, president, and chief executive officer will present at the Raymond James 47th Annual Institutional Investors Conference in Orlando, Florida on Wednesday, March 4, beginning at 10:25 a.m. ET. About Donaldson Company Founded in 1915, Donaldson (NYSE: DCI) is a global leader in technology-led filtration products and solutions,. ...

ATLANTA, Feb. 27, 2026 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Franklin BSP Realty Trust, Inc. (“FBRT” or the “Company”) (NYSE: FBRT). The lawsuit alleges that Defendants issued false and misleading statements and/or failed to disclose material adverse facts regarding FBRT’s business, operations, and prospects, including allegations that: (1) Defendants recklessly overstated FBRT’s prospects; and (2) Defendants recklessly overstated FBRT’s ability to maintain the $0.355 ...

Core Insights - Foxhaven Asset Management sold its entire stake in Wix.com for approximately $122.39 million, liquidating 689,041 shares as per a SEC filing dated February 17, 2026 [1][2]. Company Overview - Wix.com reported a total revenue of $1.93 billion and a net income of $138.90 million for the trailing twelve months (TTM) [4]. - The company's market capitalization stood at $3.79 billion, with shares priced at $68.07 as of February 17, 2026, reflecting a 70% decline over the past year [4][7]. Business Model and Competitive Advantage - Wix.com operates a scalable subscription model and offers a broad ecosystem of integrated services, which drives recurring revenue and customer engagement [6]. - The platform is recognized for its user-friendly interface and extensive feature set, catering to the diverse needs of businesses and creators in the digital economy [6][8]. Financial Performance - In the third quarter, Wix's revenue increased by 14% year-over-year to $505 million, with bookings also rising 14% to $514.5 million [7]. - The company's annual recurring revenue (ARR) from subscriptions reached $1.46 billion, and it generated $127 million in free cash flow during the quarter [9]. Market Position and Future Outlook - Despite operational stability, Wix.com has faced significant stock price declines, underperforming the S&P 500, which gained approximately 15% in the same period [7]. - Management has raised full-year bookings guidance to between $2.06 billion and $2.08 billion, driven by strong demand for its AI-driven Base44 product, expected to achieve at least $50 million in ARR by year-end [9]. - The current valuation disconnect reflects changing investor expectations, with a focus on margin pressures from AI investments and a shift towards longer-term subscription packages [10].

PayPal (PYPL) can't seem to catch a break in 2026. The stock has already dropped 21% year-to-date (YTD), following a rough 2025 in which shares lost nearly a third of their value. Then came a CEO shakeup, a disappointing profit forecast, and now a report that rival Stripe may be eyeing a buyout. Investors are understandably asking: What do you do with PYPL stock right now? More News from Barchart www.barchart.com Is PayPal Stock a Good Buy Right Now? To understand the Stripe news, you first need to u ...

FIGS Inc (NYSE:FIGS) shares are climbing on Friday after the healthcare‑apparel company delivered a standout fourth‑quarter report that blew past Wall Street expectations, with earnings coming in far stronger than analysts anticipated.FIGS stock is approaching key resistance levels. Why are FIGS shares at highs?The rally gained additional momentum after KeyBanc upgraded the stock from Sector Weight to Overweight.Earnings Strength Fuels The MoveFIGS posted earnings of 10 cents per share, far above the 2 cent ...

Core Insights - Qualcomm is expanding its presence in the utility and critical infrastructure market through a partnership with Anterix, aiming to accelerate the adoption of next-generation private wireless networks for utilities across the U.S. [1][8] Group 1: Partnership and Technology - Qualcomm will provide industrial-grade IoT chipsets, including the Snapdragon SDX35-3 and SDX32-3 modems, designed for large-scale utility deployments, enhancing mission-critical connectivity [2][8] - The Snapdragon X62 modem offers high-speed 5G connectivity with power-efficient performance, suitable for large-scale utility and industrial applications [3] - Qualcomm's 9205S modem supports cellular and satellite connectivity with low-power operation, aiding utilities in maintaining reliable coverage for smart meters and grid monitoring [3] Group 2: Market Trends - The private wireless and industrial IoT markets are rapidly growing as utilities transition to secure, low-latency LTE and 5G networks, with companies like Easymetering utilizing Qualcomm's SDX35-3 modem for advanced metering solutions [4] Group 3: Competitive Landscape - Qualcomm faces competition from Intel and Broadcom, with Intel promoting AI-enabled edge computing and rugged processors for smart grids, and Broadcom providing networking and custom chip solutions for industrial communications [5][6] Group 4: Financial Performance - Qualcomm shares have decreased by 5.7% over the past year, contrasting with the industry's growth of 59.7% [7] - The company's shares currently trade at a price/earnings ratio of 12.83, lower than the industry's 31.67 [10] - Earnings estimates for fiscal 2026 have declined by 7.5% to $11.18, while estimates for fiscal 2027 have decreased by 8.8% to $11.41 [11]

Core Insights - Jazz Pharmaceuticals has achieved a significant milestone by generating over $1 billion in annual product sales from its cannabis-derived therapy, Epidiolex, marking its entry into blockbuster territory [2][10] Group 1: Epidiolex Performance - Epidiolex generated $1.1 billion in product sales in 2025, accounting for approximately 25% of Jazz's total revenues, with a year-over-year growth of 9% driven by strong prescription demand [4][10] - The growth of Epidiolex is no longer limited to pediatric patients, with the company identifying adult patients, especially in long-term care settings, as a key growth opportunity [5] - Jazz has resolved nearly all outstanding ANDA litigations related to Epidiolex, extending patent protection into the late 2030s, which enhances revenue visibility and reduces the threat from generic competition [6][10] Group 2: Diversified Portfolio - Jazz Pharmaceuticals has a diversified biopharma portfolio that includes products in neuroscience and oncology, in addition to its cannabis-derived therapies [7] - The oxybate franchise, particularly Xywav, has become a significant growth driver, providing treatment for narcolepsy without the sodium-related warnings associated with previous formulations [8] - Oncology sales now account for over 26% of Jazz's total revenues, supported by new product launches and increasing market share [9] Group 3: Pipeline and Market Position - Despite commercial successes, Jazz has faced setbacks in its pipeline, including the discontinuation of suvecaltamide and disappointing results from a mid-stage study on JPZ150 for PTSD [12][13] - Jazz's stock has risen 11% year-to-date, outperforming the industry average of 8%, although earnings estimates present a mixed outlook for 2026 and 2027 [14][16] - Compared to pure-play cannabis companies, Jazz offers a more balanced risk profile, with recurring cash flows from its neuroscience and oncology products, while Epidiolex provides exposure to the medical cannabis market projected to exceed $130 billion by 2032 [18]

Core Insights - Block (XYZ) reported fourth-quarter 2025 adjusted earnings of 65 cents per share, meeting the Zacks Consensus Estimate and showing an increase from 47 cents per share in the prior-year quarter [1][9] - The company announced over 4000 layoffs as part of a restructuring initiative aimed at improving efficiency, which positively impacted investor sentiment, resulting in a nearly 20% increase in stock price during pre-market trading [1] Financial Performance - Net revenues for the quarter were $6.25 billion, slightly missing consensus estimates but reflecting a year-over-year increase of 3.6% [2] - Gross profit rose 24.3% year over year to $2.87 billion, with Square generating $992.7 million (up 7.5%) and Cash App generating $1.83 billion (up 33.1%) [5][9] - Adjusted EBITDA was $929.7 million, up 22.8% year over year, while operating expenses increased by 3.9% to $2.39 billion [6] Segment Performance - Commerce enablement revenues grew 11.1% to $3.05 billion, while financial solutions revenues increased significantly to $1.22 billion [3] - Bitcoin ecosystem revenues decreased by 19.6% to $1.98 billion [3] - Gross Payment Volume (GPV) was $66.94 billion, up 8% year over year, with Square's GPV at $65 billion (up 10.3%) and international GPV increasing by 24% [3][9] Cash App Insights - Cash App's GPV was $1.98 billion, showing a significant year-over-year decline [4] - Cash App's primary banking actives grew 22% year over year to 9.3 million, with monthly transacting actives reaching 59 million [6] Guidance and Future Outlook - For Q1 2026, Block expects gross profit of $2.80 billion, indicating a year-over-year growth of 22%, and adjusted operating income of $600 million with an operating margin of 21% [11] - For the full year 2026, the company anticipates gross profit of $12.20 billion, reflecting an 18% increase from 2025, and adjusted operating income of $3.2 billion with an operating margin of 26% [11] Share Repurchase Program - In Q4 2025, Block repurchased 11.9 million shares of its Class A common stock for $790 million, with an additional $5 billion authorized for share repurchase [10]